Abdominal Pain Management in Infants

Initial Approach and Pain Management

Immediate pain relief should be provided and not withheld while awaiting diagnosis, as pain control facilitates better physical examination without affecting diagnostic accuracy, according to the American Academy of Pediatrics 1
For mild to moderate pain, use oral NSAIDs if no contraindications exist, as recommended by the American Academy of Pediatrics 2
For severe pain, administer intravenous opioid analgesics titrated to effect, following guidelines from the American Society of Anesthesiologists 2

Routine use of broad-spectrum antibiotics is not indicated for all infants with fever and abdominal pain when there is low suspicion of complicated infection, as stated by the Infectious Diseases Society of America 3
Acceptable regimens for complicated intra-abdominal infection include aminoglycoside-based, carbapenem, piperacillin-tazobactam, and advanced-generation cephalosporin with metronidazole, according to the Infectious Diseases Society of America 3
For severe salmonellosis or high-risk infants, ceftriaxone may be used, as recommended by the American Academy of Pediatrics 4
Empiric antibiotic treatment without bacteriological documentation should be avoided in most cases of bacterial gastroenteritis, as advised by the Centers for Disease Control and Prevention 4

Signs of bowel obstruction require immediate further evaluation, as indicated by the American College of Radiology 5
Severe or persistent abdominal pain despite treatment, signs of dehydration, or inability to tolerate oral intake are red flags requiring immediate further evaluation, according to the American Academy of Pediatrics 1

Withholding pain medication while awaiting diagnosis is an outdated practice that impairs examination and does not improve diagnostic accuracy, as stated by the American Academy of Pediatrics 1
Routinely ordering broad-spectrum antibiotics for all infants with fever and abdominal pain is not recommended, reserve for confirmed complicated infections, as advised by the Infectious Diseases Society of America 3